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Behavioral Toxicity of Trihalomethane
Contaminants of Drinking Water in Mice
by Robert L. Balster* and Joseph F. Borzelleca*
The behavioral toxicity of trichloromethane (TCM), dichlorobromomethane (DCBM),
dibromochloromethane (DBCM) and tribromomethane (TBM) was evaluated following oral
administration in mice. Avariety ofdosageregimens and behavioral measures were used. Studies
included acute dose effect, 14- and 90-day treatments at 300 and 3000 times the estimated average
human daily intake ofcontaminated drinkingwater, 30days of100 mg/kg/day, and60days of100
and 400 mg/kg/day. In addition, TCM was tested for the production oftaste aversions with 10-day
administration and forbehavioral teratology in offspringfollowingextensive perinatal exposure.
The ED50 for acute effects on a screen test ofmotorperformance was about 500 mg/kgforall four
trihalomethanes. The 14-day treatments had no effect on swimming behavior and the 90-day
treatments had no effect on bar clinging, a test of motor coordination, and a measure of
exploratory behavior. None of the compounds produced effects on passive-avoidance learning
following 100 mg/kg/day for 30 days. TCM, DBCM and TBM elicited clear effects at both 100 and
400 mg/kg/day on operant behavior when administered for60days. DBCM elicited clear effects at
400 mg/kg/day. These effects on operant behavior were seenfollowing the first dose and tolerance
tended todevelop. Thus, there was no evidence from these studies for a progressive neurotoxicity
from trihalomethanes in adult mice. A behavioral teratology study was also conducted with
TCM. Both parents were treated with 31.1 mg/kg/day TCM, and treatment ofthe dam continued
throughout gestation and lactation. No clearevidence for behavioral effects in theoffspringwere
observed. The most sensitive measure for the effects ofTCM was the taste aversion paradigm in
which saccharin aversions were produced after a single treatment of 30 mg/kg.
Trihalomethanes are present in finished drinking
water in relatively large amounts due to their
formation during water disinfection by chlorination
(1-3). As part of a larger project to assess the
toxicity of drinking water contaminants in mice, a
number of studies of the behavioral effects of four
trihalomethaneswereconducted. Thispaperdescribes
our early approach to behavioral toxicity testing
and reviews the results.
Several considerations led to the design of the
experiments to be reported here. The mouse was
chosen as the experimental subject largely due to
its planned use by other components ofthe overall
project. The mouse is not commonly used in behav-
ioral toxicology hence most of the tests were
developed or adapted specifically for this project.
Concern with drinking water exposure dictated
that the studies use an oral route ofadministration
and that the studies include long term, daily, low
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dose exposures. Since the behavioral toxicity of
these types of exposures to trihalomethanes had
not been evaluated, there was no basis for predict-
ingwhich behavioral functions would be most likely
affected by these contaminants. For this reason, a
battery of behavioral tests were used and many
different exposure conditions were evaluated. Final-
ly, some of the dosage levels were chosen based
upon the highest levels reported in finished water
supplies at the time this research was initiated (1).
Most of the doses for long-term exposure studies
were chosen to represent 300 and 3000 times the
estimatedaveragedailyhumanintake (ADI)assum-
ing 2 liters per day intake ofthese highly contami-
nated supplies.
Methods
Subjects
With the exception of the behavioral teratology
and taste aversion experiments, all studies were128
carried out with adult male ICR mice (Flow Labo-
ratories, Dublin, Va.). They arrived in the weight
range of19-24 gand were initially housed in groups
of eight to ten in standard laboratory mouse cages
equipped with automatic watering usingtap water.
They were allowed at least one week ofadaptation
before any experimentation was carried out. With
the exception offood deprivation for operant stud-
ies, mice were allowed continuous access to Ralston-
Purina Rodent Laboratory Chow no. 5001. No spe-
cialprecautions were taken touse contaminant-free
water since we were interested in studying large
doses of selected contaminants administered by
gavage. Consumption of Richmond tap water was
considered to be amore naturalbackground against
which the effects of the trihalomethanes could be
studied.
Aftertheadaptationperiod, subjectswereassigned
randomly to groups. For most studies this resulted
in cages of six to eight mice receiving identical
treatments. For taste aversion and operant studies
the subjects were individually housed. For the ter-
atology studies both female and male ICR mice
were used, and the behavioral studies were carried
out on the offspring. For the taste aversion study,
adult male mice ofthe CD-1 strain (Charles River,
Wilmington, Mass.) were used.
Behavioral Tests
A number ofdifferent behavioral tests were used
to assess the effects of both acute and repeated
trihalomethane administration. With the exception
of the operant studies, all testing was carried out
by an experimenter blind as to the dosing condi-
tions. The following is a description of the behav-
ioral tests.
Screen Test. This is a simple test of motor
performance described originally by Coughenour et
al. (4) and is similar in some respects to the more
common rotorod. Mice were placed individually on
top of a horizontal wire mesh screen 13 x 13 cm
square placed 31 cm above the table top. Six such
screens were mounted in a row on a metal rod
which, when rotated, turned the screens upside
down. The numberofmice which climbed to the top
ofthe screen by 15, 30 and 60 sec was counted. This
measure was used to study the acute effects for
each of the trihalomethanes as well as the motor
performance ofmice receiving repeated doses. For
the latter, treatment groups were compared to
control groups by chi-square analysis. Two tests
were conducted 30 min apart beginning 24 hr after
the last dose, and the results at 15, 30 and 60 sec for
each test were analyzed separately.
Cling Test. Mice were tested fortheirabilityto
cling to a small diameter bar suspended horizon-
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tally 29 cm above a table surface. Latency to fall
was recorded up to a maximum of 60 sec. Treat-
mentandcontrolgroupswerecomparedbyone-way
analysis of variance.
Hole-Board. The hole-board has been used by a
number ofinvestigators (5,6) to assess exploratory
activity. The apparatus consisted ofa 43-cm square
plasticbox with afalse floorpositioned 17 cm above
thebottom. Thebottomwasdividedintofoursections,
and two ofthe sections contained a complex object
consistingofhardware(nuts, boltsandwires)attached
to a wooden block, and two were empty. A 3-cm
diameterholeinthe falsefloorwas situated directly
above each of the four compartments. Mice were
placed individually on the false floor and the num-
ber of head dips into holes above compartments
with or without objects were recorded separately.
Head dips were scored by an observer when the
subjects' nose and eyes were inserted into the hole.
The apparatus was wiped clean after the testing of
each subject. The test period was 3 min and sub-
jects were tested 24 hr after the last of repeated
doses of the trihalomethanes. Treatment and con-
trolgroupswerecomparedbyanunweightedmeans
two-way analysis of variance with repeated mea-
sures on one factor (groups x objects present or
absent).
SwimmingEndurance. Swimmingbehaviorwas
assessed in a30 x 30 cmcylindricaltankcontaining
water at 15°C. Animals were made heavier by
taping a length of lead wire equal to 10% of the
subjects' body weight onto their back. The weight
was placed in a way not to interfere with leg
movement. A line was drawn 2 cm below the water
level and the latency to sink below the line was
recorded. The animals were then immediately re-
moved from the tank. No subjects drowned in
carrying out these studies. Animals were tested
individually 24 hr after the last dose of repeated
dosing. Results for treatment and control groups
were compared by one-way analysis of variance.
Passive-AvoidanceLearning. Onetrialpassive
shock avoidance was assessed following repeated
contaminant exposure. A trapezoidal-shaped box
was divided into a clear "safe" compartment and a
dark "shock" compartment by a guillotine door. On
a training trial a subject was placed in the safe
compartment and the latency to enter the dark
compartmentwasrecorded. Whenthesubjectentered
the dark compartment the door was lowered and
the subject was given 5 sec ofunavoidable 40-V ac
shock via grid plates comprising the floor of the
shock compartment. One hour and 24 hr later, test
trials were conducted. They were identical to the
training trial except shock was omitted. Training
trialswereconducted24hrfollowingthelastrepeated
dose ofthe trihalomethanes. The latencies for treat-BEHAVIORAL TOXICITY OF TRIHALOMETHANES
ment and vehicle control groups were compared by
two-way analysis of variance with repeated mea-
sures on one factor (groups x test period).
Operant Behavior. Studies of the effects of
repeatedadministration oftrihalomethanes onsched-
ule-controlled performance were conducted in oper-
ant chambers designed for this study. The appara-
tus and general procedures for care and feeding of
subjects, lever press training, and experimental
control and data collection have been described
previously (7). Briefly, individually housed mice
were given 2 hr per day restricted access to food
following daily 30-min experimental sessions. They
were trained to lever press fordipperpresentations
ofsweetened milk on adifferential reinforcement of
low rate 10 sec (DRL 10) schedule, i.e., only inter-
response times of10 sec orgreater were reinforced.
Subjects were trained over a period of about two
months until response rates were stable. Subjects
werethenhabituatedtodailyvehicle gavage (5ml/kg
Emulphor:water 1:8) given 30 min prior to the on-
set of the session. At this point daily treatment
was initiated. The subjects in each treatment group
(N = 6 to 13) received a daily intubation 30 min
priorto each session, seven days per week. On occa-
sional days when sessions were not conducted, treat-
ments were continued as usual. Daily treatments
were given for 60 days or until the subjects died,
which commonly occurred inhigh dose groups. After
60 days the treatments were discontinued and the
subjects were tested for an additional 3 days follow-
ingvehicle gavage. The primary measures ofbehavior
were response rates and reinforcement rates. These
measures for the last pretreatment session and the
first treatment session were compared using a t-test
of differences.
Neurobehavioral Development. The methods
and results of behavioral teratology evaluation of
trichloromethane (TCM) have been fully reported
elsewhere (8). The offspring ofmice treated through-
out gestation and lactation were assessed for possi-
ble behavioral effects. A battery oftests ofneurobe-
havioral development, which included measures of
the righting reflex, the forelimb placing response,
forepawgrasping, therootingreflex, cliffdrop aver-
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sion, auditory startle and bar-holding ability were
assessed daily from birth through day 15. The
screen test as described above was carried out on
day 17 and passive avoidance learning on days 22
and 23.
Taste Aversion. Taste aversions produced by
TCM in adult mice have been fully described else-
where (9). Individually housed mice were gradually
adapted to 30 min per day access to water. After
fluid consumption stabilized they were given access
to a solution of 0.3% sodium saccharin during the
30-min drinking period. Immediately following the
saccharin drinkdngsessionthe subjects weregavaged
with a dose ofTCM or vehicle (N = 10 per group).
For 10 subsequent days, the subjects were given a
two bottle preference test between saccharin and
water and following each test the appropriate treat-
ment was administered. Illness-inducing effects are
seen as a conditioned aversion to the saccharin
solution with which the treatment has been paired.
Data are expressed as percent saccharin consumed
during the preference tests.
Treatments
The four trihalomethanes with their code, drink-
ing water concentration on which some ofthe doses
were chosen, and estimated average daily human
intake (ADI) are presented in Table 1. Both acute
effectsandtheeffectsofvaryingdurationsofrepeated
administration were assessed. Doses for the 14 and
90-day and behavioral teratology study were cho-
sen to represent 300 and 3000 times the estimated
ADI. Higher doses were chosen for other studies in
an attempt to determine minimally active dosage
regimens.
Thetrihalomethanes were administered by gavage
insuspensionusing avehicle of1:8Emulphor:water.
Emulphor (EL-620, GAF Corp., NY, NY) is a
polyoxyethylated oil nonionic surfactant useful for
suspendingwater-insoluble agents foradministration
to laboratory animals (10). We have found that
large volume gavage can affect mouse behavior
when administered shortly before testing. Thus,
for studies in which testing was carried out within a
Table 1. Trihalomethanes studied for behavioral toxicity.
Highest concentration, Average daily intake Lowest doses studied,
Compound Abbreviation Rg/l.a ±g/kg/dayb mg/kg/dayc
Trichloromethane TCM 311 10.4 3.1 and 31.1
Dichlorobromomethane DCBM 116 3.9 1.2 and 11.6
Dibromochloromethane DBCM 100 3.3 1.0 and 10.0
Tribromomethane TBM 92 3.1 0.9 and 9.2
aHighest concentration reported in finished drinking water (1).
bEstimated average human daily intake based upon highest concentrations reported in drinking water.
cDoses used for 14 and 90 day studies.130
few hours of dosing (operant behavior, acute dose-
effect) a volume of5 ml/kgwas used. Forlong-term
studies the injection volume was 10 ml/kg. Fresh
suspensions were prepared daily. For all repeated
dosingexperimentsthesubjectsweregavageddaily,
7 days per week, for the duration ofthe exposure.
Forsome ofthe studies, anoninjected controlgroup
was included.
Acute Effects. Acute dose-effect curves were
obtained for all four trihalomethanes on the screen
test. Tests were conducted 30, 60 and 90 min after
intubation. Five or six doses of each compound
were tested (N = 6 per dose). ED50 values were
estimated by a computer approximation (11) to the
method of Bliss (12).
The conditioned taste aversion evaluation could
also be considered a measure ofthe acute effects of
TCM since the effects appeared after the first of 10
doses. Oral doses of3, 10 and 30 mg/kg as well as a
vehicle control were assessed.
14-Day Administration. Two dose groups of
each trihalomethane (300 and 3000 times the esti-
mated ADI; Table 1), as well as vehicle and nonin-
jected control groups (N = 8 per group), were
treatedfor14days. Swimmingbehaviorwasassessed
24 hr following the last treatment.
90-Day Administration. Two doses of each
trihalomethane (300 and 3000 times the estimated
ADI; Table 1), as well as separate concurrently
treated vehicle andnoninjected controlgroups, were
exposed for 90 days. Generally eight subjects were
included in each group; however, the vehicle con-
trol group for DBCM contained six subjects, the
high dose DCBM group contained seven subjects,
andbothDBCMgroupscontained 11 subjects. Behav-
ioral testing was carried out over 2 days beginning
24 hr afterthe last treatment. Subjects were evalu-
ated on the screen test, the hole board and the cling
test.
30-DayAdministration of100 mglkg. The four
trihalomethaneswereadministeredat100mg/kg/day
for30 days. A concurrent vehicle control group was
also tested with each compound. Both treatment
and control groups consisted of 16 subjects. Passive-
avoidance learning was evaluated beginning 24 hr
following the final treatment.
60-Day Administration of 100 and 400 mglkg.
Groups of 6-13 mice trained on a DRL 10 sec
schedule ofmilk presentation were given oral treat-
ments 30 minpriorto daily behavioral testingfor60
days. Two dose groups ofeach trihalomethane (100
and 400 mg/kg) were tested as well as one vehicle
control group.
PerinatalAdministration. Maleandfemalemice
were gavaged with vehicle or 31.1 mg/kg/day TCM
for 21 days prior to mating, throughout mating (21
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days or until a vaginal plug was detected), and the
dam was continued with daily gavage throughout
gestation andlactation. Thepupswere alsogavaged
with the same dose beginning on day 7. Five TCM
and five control litters were evaluated for behav-
ioral teratology. Additional details on the methods
for this study can be read elsewhere (8).
Results
Ingeneralthetrihalomethaneswerewithouteffects
in most ofthe behavioraltests undermost exposure
conditions. TCM was investigated most thoroughly
including behavioral teratology evaluation as well
as for ability to produce a taste aversion. It was
active at 100 and 400 mg/kg/day in disrupting oper-
ant behavior; however, tolerance developed to this
effect. A single oral dose of 30 mg/kg resulted in a
clear taste aversion and tolerance did not develop
to this effect over 10 days administration. TCM did
not result in behavioral teratological effects at 31.1
mg/kg/day, norwasitactiveat3.1 or31.1mg/kg/day
for 14 days on swimming behavior or for 90 days on
three other behavioral tests.
The other trihalomethanes were not tested for
ability to produce taste aversions or for behavioral
teratology. They were all active at very high doses
of 100 and/or 400 mg/kg on operant behavior, but
were inactive at 100 mg/kg/day for 30 days on
avoidancelearning. Theywerealsoinactiveatdoses
of 300 and 3000 times the ADI for 14 days on
swimming behavior and were generally inactive
when given for 90 days on three other tests. Occa-
sionalsignificantdifferencesbetweentreatmentand
control groups were observed; but caution should
be used in interpreting these since a pattern of
effects did not emerge nor were greater effects
seen with higher doses, and many separate statisti-
cal analyses were performed.
Since many of the results were negative, all of
the data for these studies will not be presented.
Rather, selected datawillbe shown to illustrate the
conclusions stated above.
Acute Dose Effect
The acute effects of the trihalomethanes were
evaluated on the screen test at 30, 60 and 90 min
after oral administration. Effects were seen by 30
min with little evidence ofmuch change by 90 min.
Table 2 presents the ED50 values for each of the
trihalomethanes at their most active time point. All
fourcompoundswereroughlyequipotent. Theeffects
observed at high doses were ataxia and incoordina-
tion and, at the highest doses, anesthesia.BEHAVIORAL TOXICITY OF TRIHALOMETHANES
Table 2. Potency estimates of acute oral trihalomethane
administration on the screen test in mice.
ED50, 95% confidence
Compound mg/kga limits (mg/kg) Slopeb
TCM 484 243- 965 -2.6
DCBM 524 273 - 1007 -2.9
DBCM 454 262 - 788 -2.0
TBM 431 238- 788 -2.6
aDose estimated to affect 50% ofthe subjects at time ofpeak
effect. Calculated by the probit method of Baird and Balster
(11).
bIn log dose-probit units.
Repeated Administration
14-Day Administration. Groups of subjects
treated with two doses ofeachtrihalomethane were
tested for swimming endurance. The mean latency
to sink for each treatment group is provided in
Table 3. Analysis of variance revealed an overall
significant effect oftreatments [F(9,70) = 2.33, p <
0.05]; however, using Dunnett's test to compare
each group to the noninjected or vehicle control
revealed no one group to be significantly affected.
The largest effects were increases in endurance by
the low dose TCM group and the high dose TBM
group. This increased endurance by the high dose
TBM group further suggeststhatthe nonsignificant
decrease in endurance in the low dose TBM group
was not a reliable treatment effect.
90-Day Administration. The same doses that
were used in the 14-day study were used for a
90-daysubehronic study. Threebehavioralmeasures,
the cling test, screen test and hole board, were
used. Bothdosesofeachtrihalomethane weretested
simultaneously with vehicle and noninjected con-
trols. For the cling test and the screen test, the
data forthe control groups for each trihalomethane
were pooled to provide a better estimate ofcontrol
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behavior. This was done primarily because of the
relatively large within-group variability in the case
of the cling test and the poor power for detecting.
effects for the screen test due to the nominal form
of the data. This pooling resulted in 27 vehicle
controlsubjectsand28noninjectedcontrols. One-way
analysis ofvariance on the latency tofallinthe cling
test revealed no significant F-values in comparing
treatment to the pooled control groups. The results
ofthe chi-square tests comparing the effects ofthe
various treatments to the pooled control data (vehi-
cle + noninjected) for the screen test are shown in
Table 4. Forty-eight separate analyses were per-
formed. There were no effects of either dose of
TCM at any of the time points. Four of the 12
analyses forDCBMrevealed significant differences.
In all four cases, the differences were observed in
the low dose group but not in the high dose group.
Two ofthe 12 analyses for DBCM reached statisti-
cal significance. As with DCBM, effects on the
measure were observed only with the low dose, and
DBCM had no effects on the other behavioral mea-
sures at this dose. TBM had no significant effect at
either dose at any of the time points measured.
The effects ofthe 90-day treatments on the hole-
board test are presented in Table 5. Two-way anal-
yses of variance were performed on these results
for each study. No significant effects oftreatments
nor treatments by objects interaction was observed
in any ofthe studies. In the DBCM and TBM study
the subjects explored holes with objects significantly
more frequently than holes with no objects, but the
object variable was not significant in either the
TCM or DCBM study.
30-DayAdministration of100 mglkg. Figure 1
presents the results of30-day administration ofthe
trihalomethanes on latency to enter the dark com-
partment inthe passive avoidance learning test. On
the training trial prior to shock delivery, subjects
rapidly moved from the light to the dark compart-
Table 3. Effects of 14-day oral administration of trihalomethanes on swimming endurance.
Treatment Trihalomethane Mean latency
group' dose, mg/kg/day to sink, sec SEM
Noninjected control 79.7 19.8
Vehicle control - 75.5 16.2
TCM 3.1 114.7 10.2
TCM 31.1 89.6 16.9
DCBM 1.2 92.2 15.5
DCBM 11.6 80.5 13.6
DBCM 1.0 65.6 9.2
DBCM 10.0 68.9 6.9
TBM 0.9 49.1 5.1
TBM 9.7 119.4 19.1
aN = 8 mice per group.Table 4. Effects of 90-day oral administration of trihalomethanes on the screen test.
Trihalome- Trial la Trial 2a
thane dose,
Treatment mg/kg/day N 15 sec 30 sec 60 sec 15 sec 30 sec 60 sec
TCM 3.1 10 NE NE NE NE NE NE
TCM 31.1 11 NE NE NE NE NE NE
DCBM 1.2 8 NE S S S S NE
DCBM 11.6 7 NE NE NE NE NE NE
DBCM 1.0 11 NE S NE S NE NE
DBCM 10.0 11 NE NE NE NE NE NE
TBM 0.9 8 NE NE NE NE NE NE
TBM 9.2 8 NE NE NE NE NE NE
aEffects at stated times sec. during trial. Trials 1 and 2 were separated by 30 min. NE = no effect; S = significantly worse than
pooled control subjects by chi-square, p < 0.05.
Table 5. Effects of 90-day oral administration of trihalomethanes on the hole-board test.
Object present No object
Treatment groupa N Mean head dips SEM Mean head dips SEM
I. TCM Study
Noninjected 8 16.5 3.4 15.4 1.8
Vehicle 8 19.0 2.9 19.9 2.7
TCM, 3.1 8 21.7 3.1 21.1 3.8
TCM, 31.1 8 19.0 2.6 15.4 1.9
II. DCBM Study
Noninjected 8 15.5 2.8 17.2 1.5
Vehicle 6 15.0 2.2 14.7 2.7
TCM, 1.2 8 15.9 1.8 15.4 1.8
TCM, 11.6 7 20.0 1.4 18.7 2.5
III. DBCM Study
Noninjectedb 8 15.0 1.9 13.8 3.0
Vehicleb 8 19.4 3.2 13.5 2.1
TCM, 1.0 11 13.0 1.9 14.4 2.6
TCM, 10.0 11 16.4 3.0 15.0 1.9
IV. TBM Study
Noninjectedb 8 15.0 1.9 13.8 3.0
Vehicle' 8 19.4 3.2 13.5 2.1
TBM, 0.9 8 19.1 2.4 16.2 1.7
TBM, 9.2 8 14.2 1.6 12.1 1.2
aDose in mg/kg/day.
bThe DBCM and TBM studies were conducted concurrently, thus the same control groups were used.
ment with an average latency of less than 10 sec.
On the two retention trials 1 and 24 hr later, the
latency was markedly increased indicating that the
subjects learned the avoidance. Two-way analyses
of variance failed to reveal any significant treat-
ment or treatment by trial interaction. In all four
studies there was a highly significant test period
effect, i.e., the latencies increased from the train-
ingtothepost-shocktrials. Thus, 100mg/kg/day for
30 days of each of these trihalomethanes had no
effect on passive-avoidance learning or initial step-
through latency on this test.
60-Day Administration of 100 and 400 mglkg.
Figure 2 shows the mean daily response rates for
the vehicle control group throughout the 60 days of
treatment plus the three pre- and post-treatment
days. Seven subjects began this regimen. One died
from a faulty injection on day 5; thus six subjects
completed the study. As can be seen in Figure 2,
responseratesremained quite stable overthe course
of the study and the variability decreased as all of
the subjects' performance in the task improved.
Rates of reinforcement (not shown) rose steadily
from 2.71 reinforcements/min on day 1 to 3.3 rein-
forcements/min on day 60.
Figure 3 presents the effects of 400 mg/kg/day
TCM on response rates. These results were typical
of the effects of active doses of the other trihalo-
methanes as well. Thirteen subjects began this
treatment; however, six died by day 25, thus only
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FIGURE 1. Effects of 100 mg/kg/day of (
trichloromethane (TCM), dichlorobromethane (DCBM),
dibromochloromethane (DBCM) and tribromomethane
(TBM) or (---) vehicle following 30 days of oral
administration on passive-avoidance learning in mice.
seven completed this treatment regimen. Animals
commonly died during these high dose regimens.
Typically their schedule-controlled behavior was
unchanged until a few days before they died. It can
be seen from the figure that there was an initial
large effect of400 mg/kg given 30 min prior to the
session. Response rates and reinforcement rates
(not shown) werebothsubstantiallydecreased. How-
ever, rather than a progressive deterioration of
performance over the 60-day regimen, some toler-
ance developed tothe initialeffects. Variability also
decreased over the 60 days although never to the
extent seen in the control subjects (Fig. 2). There
was no significant effect on the first day following
discontinuation of TCM treatment.
This general pattern ofeffects on the first day of
treatment with partial tolerance development was
seen with all active doses of the trihalomethanes.
Table 6 compares response rates and reinforcement
rates on the last pretreatment day and the first
treatmentdayinallninegroups. Significantdecreases
in response rate, usually accompanied by significant
changes in reinforcement rates, were seen with all
trihalomethane groupsexceptthe 100mg/kgDBCM
group.
Therefore, operant behavior was affected by 100
mg/kg/day of TCM, DCBM and TBM and by 400
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FIGURE 2. Effects of 60 days of an Emulphor:water
vehicle on response rates of mice trained on a
differential reinforcement of low rate 10 sec schedule
of milk presentation. The three open circles prior to
and following the 60 days also represent effects of
vehicle administration. Treatments were adminis-
tered by gavage 30 min prior to 30-min experimental
sessions.
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FIGURE 3. Effects of 60 days of 400 mg/kg/day trichlo-
romethane on response rates of mice trained on a
differential reinforcement of low rate 10 sec schedule
ofmilk presentation. Details the same as in Figure 2.
mg/kg/dayofallfourtrihalomethanes. Greatesteffects
were observed early in the regimen with no evi-
dence for progressive behavioral deterioration; in
fact, partial tolerance occurred to the effects of
these contaminants.
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ITable 6. Effects of the first day oforal trihalomethane administration on schedule-controlled behavior.
Responses per minute Reinforcements per minute
Last pretreatment day First treatment day Last pretreatment day First treatment day
Treatment groupa N (mean ± SEM) (mean ± SEM) (mean ± SEM) (mean ± SEM)
Vehicle 7 4.89 ± 0.91 4.89 ± 0.95 2.93 ± 0.57 2.71 ± 1.07
TCM, 100 12 8.60 ± 0.51 6.38 ± 0.53b 2.06 ± 0.70 2.67 ± 0.79"
TCM, 400 13 7.40 ± 0.46 2.05 ± 0.53b 2.58 ± 0.28 1.23 ± 0.29b
DCBM, 100 8 7.20 ± 0.61 4.97 0 O.76c 2.55 ± 0.16 2.54 ± 0.14
DCBM, 400 11 6.84 ± 0.35 2.80 ± 0.56b 2.99 ± 0.13 1.39 +0.23b
DBCM, 100 7 5.85 ± 1.01 5.29 ± 1.12 2.93 ± 0.34 2.50 ± 0.28
DBCM, 400 12 6.94 ± 0.61 1.74 ± 0.58b 2.98 ± 0.21 0.96 ± 0.26b
TBM, 100 8 5.95 ± 0.14 4.97 ± 0.42c 3.22 ± 0.15 3.23 ± 0.10
TBM, 400 6 5.95 ± 0.27 2.86 1.28C 3.23 ± 0.23 1.62 ± 0.75c
aDose in mg/kg/day.
bp < 0.01, paired t-test between last pretreatment day and first treatment day.
cp < 0.05, paired t-test between last pretreatment day and first treatment day.
Perinatal Administration
Only the effects of perinatal administration of
TCM were evaluated. These results have been
reported elsewhere (8). Repeated dosing of the
parents through gestation and lactation and the
pups from 7 days of age until weaning with 31.1
mg/kg/dayhadnoconsistenteffectonneurobehavioral
development nor on motor performance or passive
avoidance learning. The only significant difference
between the TCM and vehicle groups was in fore-
limb placement on days 5 and 7. Since many sepa-
rate analyses were performed and no differences
were seen in other measures of development of
function of the extremities (forepaw grasping, bar
holding), we did not place much confidence in the
reliability of this TCM effect. Thus, there is little
evidence ofbehavioral teratological effects ofTCM
at 31.1 mg/kg/day.
Taste Aversion
Taste aversions produced by TCM have been
reported elsewhere (9). Oral doses of 3 and 10
mg/kg/day were without effect after the first day
and an aversion to the saccharin did not appear
with 10 days of treatment. A significant saccharin
aversion was produced after a single pairing with
30 mg/kg TCM and over 10 days of repeated pair-
ings the aversion increased to the point that almost
no saccharin was consumed during the two-bottle
choice test.
Discussion
A summary of the results of behavioral toxicity
evaluation oftrihalomethanes is presented in Table
7. TCMhasbeenevaluatedmostextensively. Acute-
ly, TCM is notveryactive onmostbehavioraltests.
Its ED50 on a simple test of motor performance
probably measuring the CNS depressant proper-
ties ofhigh doses was 484 mg/kg. This dose is about
one-halfthe LD50 obtained under similar conditions
(13). On the more sensitive measures of schedule-
controlled behavior, significant effects were seen at
100 mg/kg. These effects occurred with the first
dose and, rather than progressive deterioration of
behavior with repeated doses, there was some
evidence for tolerance development. Since doses
lowerthan 100 mg/kgwere not tested with operant
behavior, the minimal active dose cannot be deter-
mined, but based upon the magnitude ofthe effects
seen we would not expect doses much lower than
100mg/kgto have had an effect. The most sensitive
measures ofthe acute effects ofTCM was the taste
aversionparadigm (9). Oral doses of3 and 10mg/kg
were inactive but 30 mg/kgproduced a clear effect.
Althoughtaste aversions are abehavioral measure,
this does not mean that the toxic effect producing
this aversion is mediated by the central nervous
system. Taste aversions can be produced by many
types of illness-causing agents (14).-We do not
believe that this effect of30 mg/kgTCM was due to
a localized gastric irritation, however, since an
even lower dose could produce the aversion by the
IP route.
The remainder of the behavioral evaluation of
TCM was designed explicitly not to measure acute
effects since testing was not carried out until 24 hr
following the last treatment. In these studies we
were looking for evidence of relatively permanent
behavioral changes. A variety of measures and
dosage regimens were used, but even up to 100
mg/kg/day for 30 days there was no evidence for
behavioraltoxicity. Themeasuresused(screentest,
cling test, hole-board, swimming and passive-
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Table 7. Summary of behavioral toxicity evaluation of trihalomethanes.
Effecta
TCM DCBM DBCM TBM
Acute ED50, mg/kg 484 524 454 431
14-day, swimming
300 times ADI/day No No No No
3000 times ADI/day No No No No
90-day, cling, screen and hole-board
300 times ADI/day No Nob Noc No
3000 times ADI/day No No No No
30-day 100 mg/kg, learning No No No No
60-day, operant behavior
100 mg/kg/day Yes Yes No Yes
400 mg/kg/day Yes Yes Yes Yes
Perinatal administration
31.1 mg/kg/day No NT NT NT
Taste aversion
3 mg/kg/day No NT NT NT
10 mg/kg/day No NT NT NT
30 mg/kg/day Yes NT NT NT
aNo = no effect; yes = significant effect; NT = not tested.
bFour of 12 screen tests were significant, but no clear pattern suggesting behavioral toxicity.
CTwo of 12 screen tests were significant, but no clear patterns suggesting behavioral toxicity.
avoidance learning) were not selected to be particu-
larly sensitive, but rather as initial screening tools.
Had effects at these high doses been found, lower
doses would have been tested in more sensitive
measures (e.g., operantbehavior). Inaddition, effects
were not seenas aresult ofperinatal administration
of31.1 mg/kg/day. This study can be considered an
initial screening of the behavioral toxicity associ-
ated with long-term oral TCM exposure. There is
no evidence from these results with doses 300 and
3000 times or more the ADI ofTCM from contami-
nated drinking water that progressive neurobe-
havioral toxicity is likely to be a problem.
The other trihalomethanes were not evaluated
quite as extensively as TCM, butwhat datathere is
suggests that they, too, are not very active behav-
iorally(Table 7). The ED50values ofDCBM, DBCM
and TBM were comparable to those for TCM. With
the exception of DBCM they all had effects at 100
mg/kgon operant behavior. Allthetrihalomethanes
had pronounced effects on operant behavior at 400
mg/kg/day. Like these effects of TCM, effects on
operant behavior were greater early in the 60-day
treatment regimen; thus they were not progres-
sive. Fourteen and 90-day studies of 300 and 3000
times the ADI of DCBM, DBCM and TBM were
without consistent behavioral effects. Occasional
significant differences were observed between treat-
ment and control groups but these should be inter-
preted with caution. For example, 90-day admini-
stration of the low dose of DCBM (1.2 mg/kg/day)
had a significant effect on the screen test of motor
coordination on 4 of the 12 analyses performed. In
assessing the implications ofthis, it should be kept
in mind that: (1) with a large number of statistical
analyses performed somewillbesignificantbychance;
(2) these four differences are not independent obser-
vations, since once a subject has fallen from the
screen by 30 sec (as six did at the low dose on trial
1), they will also be counted as fallen at 60 sec; (3)
the effects were only seen with the low dose; (4) no
effect of DCBM was seen in the cling test or hole-
board tested in these same subjects. Nevertheless,
it is possible that DCBM may have some neurobe-
havioral effects that were not dose-dependent and
which mayneed tobe evaluated by furtherresearch.
However, even30-daytreatmentwith100mg/kg/day
ofany ofthe trihalomethanes had no effects on any
of the measures obtained from a passive avoidance
learningtask. Wehave notevaluated DCBM, DBCM
or TBM forbehavioralteratology and they have not
been tested in the taste aversion paradigm. The
latter would be most interesting to do since it was
most sensitive to the effects of TCM.
The evaluation ofthe behavioral toxicity oftrihalo-
methanes represented our first efforts in the assess-
ment ofthe safety ofdrinking water contaminants.
As a result of this experience, we have made a
number ofchanges in the behavioral battery as well
as in the choice of dosage regimens (15,16). Subse-
quent studies have not based the choice ofdoses on
ADI's estimated from reports of levels of drinking
water contamination. Rather, an attempt is now
made to determine maximal no-effect levels. This is
doneby choosingdoses forrepeated exposurebased
upon the acute behavioral and lethal effects. Doses
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for 14-day studies are chosen as 1/10 and 1/100 ofthe
LD50 for the chemical. If no adverse behavioral
effects are observed in the subacute study, then
the subchronic study is executed at the same doses.
In addition, where feasible, the subchronic studies
are carried out by exposing subjects viatheirdrink-
ing water rather than by daily gavage. If this
approach to dosage choices had been used with the
trihalomethanes, then the 14- and 90-day studies
would have been carried out at substantially higher
doses. The use of higher doses would have allowed
us to make a better estimate of minimal effective
dosage regimens for behavioral effects.
We have also made changes in the dependent
measures as a consequence of our experience with
the trihalomethanes (15,16). A number ofnew mea-
sureshave beenadded. Theyincludephotocell motor
activity, body weight, food intake, a standardized
behavioral observation, body temperature measure-
ment, sensorytests (olfaction andnociception), social
behavior, and taste aversion testing. In addition,
unlike the case for the trihalomethanes where most
testing was initiated one day after the last dose of
the regimen, many of the assessments are now
made throughout the exposure. We no longer use
the hold-board test since we believe that photocell
motor activity is assessing some ofthe same behav-
ioralfunctions. The screen test has beenmodified to
record latency to climb to the top of the screen
rather than the nominal result ofsuccess or failure.
On the other hand, few changes have been made in
our approach to behavioral teratology assessment.
Operant behavioral testing has been deemphasized
since it lends itself best to within-subjects designs
andin ascreeningprogramthelarge effortrequired
may not be justified. We still find it useful to
characterize maximal no effect levels by a proce-
dure involving an ascending dosage series which
continues until effects are found.
In conclusion, we have presented our evaluation
ofthebehavioraltoxicity oftrihalomethane contam-
inants of drinking water. The purpose of these
studies was twofold: to develop an approach to
safety evaluation of drinking water contaminants
and to provide some data on the behavioral effects
of trihalomethanes. The trihalomethanes have not
proven to be very active on most behavioral tests
and thus regulatory decisions for these compounds
are unlikely to need to focus on behavioral toxicity.
Our results with the trihalomethanes, however,
have been very helpful in the development of a
strategy for assessment of the behavioral toxicity
of drinking water contaminants.
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